Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

Shining a Spotlight on Patient Advocate Involvement at SABCS

When patient advocates attend major conferences like the San Antonio Breast Cancer Symposium (SABCS), they help shape breast cancer clinical trials by sharing what patients really experience and need when it comes to research. They also help to translate complex science into clear, understandable information that helps patients make informed choices. That’s why patient advocate involvement is so important for improving clinical trials for patients.  In this installment of Spotlight on Clinical Trials, we explore just a few of the many ways that advocates help shape clinical trials and make a […]

Three adults stand smiling outdoors on a sunny day. The person in the center, living with metastatic breast cancer, wears a headscarf and a "Stronger Than Cancer" shirt as their companions stand close, showing support. Trees and parked cars are behind them.

Sonja’s Story: Determination in the Face of Metastatic Breast Cancer

Sonja Rideout’s diagnosis of HER2-positive breast cancer – and later the news it had progressed to metastatic breast cancer – changed her life in ways she never imagined. Through uncertainty and evolving treatment plans, she found strength in the Race for the Cure community and has raised nearly $60,000 to help support others facing breast cancer.

Breast Cancer Breakthroughs Episode 18: Right-Sizing Breast Cancer Treatment Through Dose Optimization 

Breakthroughs in breast cancer don’t always mean the development of new drugs – they’re also made by optimizing currently available treatments. Researchers are re-examining some breast cancer treatments through dose optimization.   Maximum tolerated dose (MTD) has been the status quo in breast cancer treatment. Clinical trials determine the MTD by finding the highest drug or treatment amount (dose) with acceptable or tolerable side effects for participants. However, some individuals receiving treatments at MTD still experience significant […]